Sanofi-Aventis, the world's third-largest pharmaceutical company, has named Euro RSCG Worldwide its global agency in charge of all communications for Lovenox/Clexane, a leading product for thrombosis
treatment, and Lantus and Apidra, which treat diabetes. This is the first global pharmaceutical client for the company. Sanofi-Aventis has enlarged its partnership with Euro RSCG Life by awarding the
agency the responsibility of launching all communications programs for all new brands in these two therapeutic domains.